AnalyzeDirect Contractor KB, Kenny LM, Stebbing J, Challapalli A, Al-Nahhas A, Palmieri C, Shousha S, Lewis JS, Hogben K, De Nguyen Q, Coombes RC, Aboagye EO. Biological basis of [11)C]choline-positron emission tomography in patients with breast cancer: comparison with [18F]fluorothymidine positron emission tomography. Nucl Med Commun. November 2011;32(11):997-1004.
Publication Date
November 2011
How Analyze was Used
“Volumes of interest were then drawn manually around the entire tumour over multiple slices (minimum of four slices) using Analyze software.”
Keywords
Adenocarcinoma/pathology/radionuclide imaging
Adult
Aged
Breast Neoplasms/pathology/radionuclide imaging
Carbon Radioisotopes/diagnostic use
Cell Proliferation
Choline/diagnostic use
Choline Kinase/metabolism
Female
Fluorodeoxyglucose F18/diagnostic use
Humans
Ki-67 Antigen/blood/metabolism
Middle Aged
Positron-Emission Tomography (PET)/methods
Radiopharmaceuticals/diagnostic use
Author Affiliation(s)
Department of Oncology, Imperial College London, London, UK.
ID# 741
Tags: Adenocarcinoma/pathology/radionuclide imaging, Adult, Aged, Breast Neoplasms/pathology/radionuclide imaging, Carbon Radioisotopes/diagnostic use, Cell Proliferation, Choline Kinase/metabolism, Choline/diagnostic use, Female, Fluorodeoxyglucose F18/diagnostic use, Humans, Ki-67 Antigen/blood/metabolism, Middle Aged, Positron-Emission Tomography (PET)/methods, Radiopharmaceuticals/diagnostic use